CASEID,PRIMARYID,CASEVERSION,I_F_CODE,EVENT_DT,MFR_DT,INIT_FDA_DT,FDA_DT,REPT_COD,AUTH_NUM,MFR_NUM,MFR_SNDR,LIT_REF,AGE,AGE_COD,AGE_GRP,SEX,E_SUB,WT,WT_COD,REPT_DT,TO_MFR,OCCP_COD,REPORTER_COUNTRY,OCCR_COUNTRY,DRUGNAME,PT,PRIMARYID_OUTC,OUTC_COD,PRIMARYID_RPSR,RPSR_COD,PRIMARYID_THER,DSG_DRUG_SEQ,START_DT,END_DT,DUR,DUR_COD,PRIMARYID_INDI,INDI_DRUG_SEQ,INDI_PT
10041607,100416074,4,F,20130125,20141208,20140327,20141211,EXP,,US-GILEAD-2014-0097252,GILEAD,,,,,,Y,,,20141217,N,MD,US,US,SUSTIVA,Amniotic cavity infection;Delayed delivery;Pregnancy,100416074,OT,,,100416074,1,20120524,20130228,,,100416074,1,HIV infection
10096170,100961705,5,F,20140312,20141014,20140422,20141017,EXP,,MW-GILEAD-2014-0097032,GILEAD,,28,YR,A,F,Y,50.2,KG,20141017,N,MD,MW,MW,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Anaemia;Immune reconstitution inflammatory syndrome associated tuberculosis,100961705,OT,,,100961705,1,20140227,,,,100961705,1,HIV infection
10128416,101284163,3,F,20130422,20141210,20140428,20141221,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19010255,BRISTOL MYERS SQUIBB,,31,YR,,M,Y,,,20150106,N,CN,US,ZA,EFAVIRENZ,Hyponatraemia;Tuberculosis,101284163,OT,,,101284163,1,20130422,20130516,,,101284163,1,Tuberculosis
10363037,103630372,2,F,,20141015,20140805,20141020,EXP,,ZA-GILEAD-2014-0110661,GILEAD,"MOODLEY A, BHOLA S, OMAR F, MOGAMBERY J. FIRST REPORT OF LEBER^S HEREDITARY OPTIC NEUROPATHY: 2 CASE REPORTS. REACTIONS 1522. 2014;UNK:106-11",,,,,Y,,,20141218,N,,COUNTRY NOT SPECIFIED,ZA,EFAVIRENZ,Hereditary optic atrophy,103630372,OT,,,,,,,,,103630372,1,HIV infection
10363144,103631442,2,F,,20141015,20140805,20141021,EXP,,ZA-GILEAD-2014-0110663,GILEAD,"MOODLEY A, BHOLA S, OMAR F, MOGAMBERY J. FIRST REPORT OF LEBER^S HEREDITARY OPTIC NEUROPATHY: 2 CASE REPORTS. REACTIONS 1522. 2014;UNK:106-11",,,,,Y,,,20141217,N,,COUNTRY NOT SPECIFIED,ZA,EFAVIRENZ,Hereditary optic atrophy,103631442,OT,,,,,,,,,103631442,1,HIV infection
10372108,103721082,2,F,201406,20141015,20140808,20141024,EXP,,DE-ABBVIE-14K-062-1268573-00,ABBVIE,,45,YR,,M,Y,68,KG,20141024,N,MD,COUNTRY NOT SPECIFIED,DE,SUSTIVA,Acute hepatic failure;Acute kidney injury;Atelectasis;C-reactive protein increased;Cholestasis;Gamma-glutamyltransferase increased;General physical health deterioration;Generalised oedema;Hepatic cirrhosis;Loss of consciousness;Lymphadenitis;Nephrolithiasis;Pleural effusion;Procalcitonin increased;Renal abscess;Respiratory disorder;Splenomegaly;Urosepsis;White blood cell count increased,103721082,HO,,,103721082,1,201204,201407,,,103721082,1,Psoriatic arthropathy
10376544,103765442,2,F,20140729,20141029,20140811,20141104,EXP,,ZW-GILEAD-2014-0111207,GILEAD,,48,YR,A,F,Y,43.1,KG,20141104,N,MD,ZW,ZW,EFAVIRENZ,Anaemia;Renal failure,103765442,DE,,,103765442,1,20131120,20140729,,,103765442,1,HIV infection
10397998,103979982,2,F,20140721,20141023,20140821,20141029,EXP,,BW-BRISTOL-MYERS SQUIBB COMPANY-21322235,BRISTOL MYERS SQUIBB,,3,WK,I,M,Y,1.9,KG,20141029,N,CN,US,BW,EFAVIRENZ,Premature baby;Respiratory distress,103979982,HO,,,103979982,1,20110822,20140204,,,,,
10399711,103997112,2,F,20140204,20141023,20140821,20141030,EXP,,BW-BRISTOL-MYERS SQUIBB COMPANY-21316401,BRISTOL MYERS SQUIBB,,35,YR,,F,Y,,,20141030,N,CN,BW,BW,EFAVIRENZ,Pregnancy;Vaginal discharge,103997112,OT,,,103997112,1,20110822,,,,103997112,1,HIV infection
10409897,104098972,2,F,20140721,20141023,20140826,20141030,EXP,,BW-GILEAD-2014-0112399,GILEAD,,0,DY,,M,Y,,,20141030,N,MD,BW,BW,EFAVIRENZ,Acute respiratory distress syndrome;Premature baby,104098972,OT,,,104098972,1,20140204,20140721,,,104098972,1,HIV infection
10457106,104571063,3,F,20130803,20141024,20140916,20141030,EXP,,US-GILEAD-2014-0114765,GILEAD,,42,YR,A,F,Y,52,KG,20141030,N,MD,UG,UG,EFAVIRENZ,Ascites;Cirrhosis alcoholic;Decreased appetite;Diarrhoea;Glomerulonephritis;Vomiting,104571063,OT,,,104571063,1,20131211,20140811,,,104571063,1,HIV infection
10459838,104598382,2,F,20140901,20141024,20140917,20141103,EXP,,MW-GILEAD-2014-0115094,GILEAD,,30,YR,A,F,Y,,,20141103,N,MD,MW,MW,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis,104598382,HO,,,104598382,1,20140812,20140909,,,104598382,1,HIV infection
10473973,104739732,2,F,,20141210,20140924,20141218,EXP,,CA-GILEAD-2014-0115852,GILEAD,,46,YR,A,M,Y,70,KG,20141218,N,MD,CA,CA,EFAVIRENZ,Blood HIV RNA increased;Drug ineffective;Neuropsychiatric syndrome;Tuberculosis;Viral mutation identified,104739732,OT,,,104739732,1,20140220,201406,,,104739732,1,HIV infection
10486199,104861992,2,F,201212,20140917,20141001,20141001,EXP,,CN-RANBAXY-2014R1-80584,RANBAXY,"HU Z, WEI H, MENG F, XU C, CHENG C, YANG Y. RECURRENT CRYPTOCOCCAL IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN AN HIV-INFECTED PATIENT AFTER ANTI-RETROVIRAL THERAPY: A CASE REPORT. ANN-CLIN-MICROBIAL-ANTIMICROB. 2013;12(40):5 PAGES",19,YR,,M,Y,,,20141001,N,OT,CN,CN,Efavirenz,Central nervous system lesion;Cryptococcosis;Immune reconstitution inflammatory syndrome;Lymphadenopathy mediastinal,104861992,OT,,,104861992,1,201109,,,,104861992,1,Antiretroviral therapy
10487575,104875751,1,I,,20140917,20141001,20141001,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-21423868,BRISTOL MYERS SQUIBB,,,,,,Y,,,20141001,N,CN,ZA,ZA,EFAVIRENZ,Completed suicide;Nervous system disorder,104875751,OT,,,,,,,,,104875751,1,HIV infection
10494095,104940952,2,F,20140913,20141003,20141003,20141017,EXP,,KE-BRISTOL-MYERS SQUIBB COMPANY-21434980,BRISTOL MYERS SQUIBB,,30,YR,,M,Y,,,20141017,N,CN,GB,KE,EFAVIRENZ,Cerebellar infarction;Cerebral toxoplasmosis;Death;Diarrhoea;Meningitis;Oral candidiasis,104940952,DE,,,104940952,1,20140910,20140927,,,104940952,1,HIV infection
10494815,104948151,1,I,20140902,20140926,20141003,20141003,EXP,,FR-AMGEN-FRASP2014074909,AMGEN,,16,YR,T,F,Y,,,20141003,N,OT,FR,FR,SUSTIVA,Pain,104948151,HO,,,104948151,1,20140804,20140902,,,104948151,1,Thrombocytopenia
10495703,104957031,1,I,,20140919,20141003,20141003,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-21429014,BRISTOL MYERS SQUIBB,,41,YR,,M,Y,,,20141003,N,CN,CA,CA,SUSTIVA,Drug interaction;Virologic failure,104957031,OT,,,,,,,,,104957031,1,HIV infection
10499423,104994232,2,F,,20141015,20141006,20141023,EXP,,US-GILEAD-2014-0117321,GILEAD,HENRICH  T ET AL. ANTIRETROVIRAL-FREE HIV-1 REMISSION AND VIRAL REBOUND AFTER ALLOGENEIC STEM CELL TRANSPLANTATION. TOPICS IN ANTIVIRAL MEDICINE. 2014;-:471-472,,,C,M,Y,,,20141023,N,MD,US,US,EFAVIRENZ,Acute HIV infection;Blood HIV RNA increased;Blood creatinine increased;Drug ineffective;Meningitis,104994232,HO,,,,,,,,,104994232,1,HIV infection
10502435,105024351,1,I,20040216,20140926,20141007,20141007,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-21452552,BRISTOL MYERS SQUIBB,,45,YR,,M,Y,79,KG,20141007,N,CN,FR,FR,SUSTIVA,Vertigo,105024351,DS,,,105024351,1,20040216,20140912,,,105024351,1,HIV infection
10503124,105031242,2,F,20140917,20141029,20141007,20141105,EXP,,KE-GILEAD-2014-0117337,GILEAD,,30,YR,A,M,Y,,,20141105,N,MD,KE,KE,EFAVIRENZ,Cerebellar infarction;Cerebral toxoplasmosis;Diarrhoea;Oral candidiasis,105031242,DE,,,105031242,1,20140910,20140927,,,105031242,1,HIV infection
10507885,105078851,1,I,,20140929,20141009,20141009,EXP,,PHHY2014US131418,SANDOZ,"HENRICH TJ, HANHAUSER E, MARTY FM, SIRIGNANO MN, KEATING S, LEE T-H ET AL. ANTIRETROVIRAL-FREE HIV-1 REMISSION AND VIRAL REBOUND AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: REPORT OF 2 CASES. ANN-INTERN-MED. 2014;161 (5):319-327",,,,M,Y,,,20141009,N,OT,US,US,EFAVIRENZ,Acute HIV infection;Drug resistance;Headache;Meningitis viral;Nausea;Pleocytosis;Pyrexia;Vomiting,105078851,OT,,,,,,,,,105078851,1,Prophylaxis against graft versus host disease
10510082,105100821,1,I,,20140930,20141010,20141010,EXP,,US-JNJFOC-20141001264,MCNEIL,"OVERTON ET, CHAN ES, BROWN TT, TEBAS P, MCCOMSEY GA, MELBOURNE KM, ET AL. HIGH-DOSE VITAMIN D AND CALCIUM ATTENUATES BONE LOSS WITH ART INITIATION: RESULTS FROM ACTG A5280. TOPICS IN ANTIVIRAL MEDICINE 21ST CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS MAR-2014;22 (E-1):66-67.",,,A,,Y,,,20141010,N,OT,US,US,EFAVIRENZ,Toxicity to various agents,105100821,OT,,,,,,,,,105100821,1,Bone density decreased
10511011,105110111,1,I,,20141007,20141010,20141010,EXP,,CA-ABBVIE-14P-028-1293742-00,ABBVIE,,,,,M,Y,,,20141010,N,OT,CA,CA,SUSTIVA,Abnormal dreams;Drug interaction;Erectile dysfunction;Liver injury;Nail disorder;Renal impairment;Skin ulcer;Thirst;Visual acuity reduced,105110111,OT,,,,,,,,,105110111,1,Product used for unknown indication
10511165,105111651,1,I,,20140929,20141010,20141010,EXP,,US-MYLANLABS-2014M1006710,MYLAN,"HENRICH TJ, HANHAUSER E, MARTY FM, SIRIGNANO MN, KEATING S, LEE T-H, ET AL. ANTIRETROVIRAL-FREE HIV-1 REMISSION AND VIRAL REBOUND AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: REPORT OF 2 CASES. ANN-INTERN-MED 2014; 161(5) 319-327",,,,,Y,,,20141010,N,MD,US,US,EFAVIRENZ,Condition aggravated;Meningitis viral;Pathogen resistance,105111651,OT,,,,,,,,,105111651,1,Graft versus host disease
10518435,105184353,3,F,20140918,20141224,20141015,20141229,EXP,,GB-JNJFOC-20141004457,JANSSEN,,60,YR,A,F,Y,,,20150113,N,PH,GB,GB,EFAVIRENZ,Acute kidney injury,105184353,OT,,,,,,,,,105184353,1,Antiretroviral therapy
10520186,105201861,1,I,,20141010,20141015,20141015,EXP,,US-GILEAD-2014-0118545,GILEAD,,52,YR,A,F,Y,,,20141015,N,CN,US,US,SUSTIVA,Nasal congestion,,,,,105201861,1,20140814,,,,105201861,1,Product used for unknown indication
10520712,105207121,1,I,201407,20141009,20141015,20141015,EXP,FR-ANSM-LY20141238,FR-GILEAD-2014-0118249,GILEAD,,30,YR,A,M,Y,,,20141015,N,OT,FR,FR,SUSTIVA,Osteoporosis,105207121,OT,,,105207121,1,20061114,20140803,,,105207121,1,HIV infection
10522442,105224421,1,I,,20140825,20141016,20141016,EXP,,US-GILEAD-2014-0118770,GILEAD,"SANGHA MS, CRAWFORD K, KURUVILA A. FANCONI SYNDROME. AMERICAN JOURNAL OF KIDNEY DISEASES. CONFERENCE: NATIONAL KIDNEY FOUNDATION 2014. 2014;63(5):A97",58,YR,A,F,Y,,,20141016,N,MD,US,US,EFAVIRENZ,Acute kidney injury;Asthenia;Decreased appetite;Fanconi syndrome acquired;Lethargy;Metabolic acidosis;Renal tubular acidosis;Septic shock,105224421,OT,,,,,,,,,105224421,1,HIV infection
10522491,105224912,2,F,201408,20141001,20141016,20141016,EXP,,MX-BRISTOL-MYERS SQUIBB COMPANY-21445820,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20141016,N,CN,US,MX,EFAVIRENZ,Depression;Rash,105224912,HO,,,,,,,,,,,
10523723,105237231,1,I,,20141009,20141017,20141017,EXP,,US-DRREDDYS-USA/USA/14/0043532,DR REDDYS,"HENRICH T, HANHAUSER E, MARTY F, SIRIGNANO M, KEATING S, LEE T, ET AL. ANTIRETROVIRAL-FREE HIV-1 REMISSION AND VIRAL REBOUND AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: REPORT OF 2 CASES. ANN INTERN MED. 2014;161(5):319-27.",,,,M,Y,,,20141017,N,MD,COUNTRY NOT SPECIFIED,US,efavirenz,Blood HIV RNA increased,105237231,OT,,,,,,,,,105237231,1,Prophylaxis
10525210,105252101,1,I,20131206,20141006,20141017,20141017,EXP,,ZW-BRISTOL-MYERS SQUIBB COMPANY-21487632,BRISTOL MYERS SQUIBB,,41,YR,,F,Y,62,KG,20141017,N,CN,US,ZW,EFAVIRENZ,Cellulitis,105252101,HO,,,105252101,1,20110621,20140902,,,105252101,1,HIV infection
10525222,105252221,1,I,20140922,20141006,20141017,20141017,EXP,,UG-BRISTOL-MYERS SQUIBB COMPANY-21477542,BRISTOL MYERS SQUIBB,,42,YR,,M,Y,,,20141021,N,CN,US,UG,EFAVIRENZ,Death,105252221,DE,,,105252221,1,20140917,20140921,,,105252221,1,HIV infection
10525299,105252994,4,F,201406,20141106,20141015,20141118,EXP,,JP2014JPN001749,VIIV,,73,YR,,M,N,,,20141117,N,MD,JP,,STOCRIN (EFAVIRENZ),Eczema;Pain of skin;Pigmentation disorder;Pruritus;Rash macular;Scar;Scratch,,,105252994,HP,105252994,1,201406,,,,105252994,1,HIV infection
10525523,105255231,1,I,20140902,20141008,20141017,20141017,EXP,,UG-GILEAD-2014-0118171,GILEAD,,20,YR,A,M,Y,,,20141017,N,MD,UG,UG,EFAVIRENZ,Bladder outlet obstruction;Gastritis;Glomerulonephritis,105255231,LT,,,105255231,1,20140811,20140909,,,105255231,1,HIV infection
10528620,105286201,1,I,,20141010,20141020,20141020,EXP,,PHHY2014MW133329,SANDOZ,"KUDZALA A, CASHMAN J, VAN OOSTERHOUT JJ.. CASE REPORT: A MAN ON ANTIRETROVIRAL THERAPY WITH PAINFUL THIGHS. MALAWI MEDICAL JOURNAL. 2013;25 (1):24-25",54,YR,,M,Y,,,20141020,N,OT,MW,MW,EFAVIRENZ,Arthralgia;Osteonecrosis;Pain in extremity,105286201,OT,,,,,,,,,105286201,1,Antiretroviral therapy
10530061,105300611,1,I,,20141013,20141021,20141021,EXP,,ZA-AUROBINDO-AUR-APL-2014-10972,AUROBINDO,,31,YR,,M,Y,,,20141020,N,MD,ZA,ZA,Efavirenz,Blindness;Colour blindness;Hereditary optic atrophy;Optic atrophy;Pupillary reflex impaired;Visual acuity tests abnormal;Visual evoked potentials abnormal,105300611,OT,,,,,,,,,105300611,1,HIV infection
10530241,105302411,1,I,,20141013,20141021,20141021,EXP,,ZA-AUROBINDO-AUR-APL-2014-11041,AUROBINDO,,33,YR,,M,Y,,,20141020,N,MD,ZA,ZA,Efavirenz,Blindness;Colour blindness;Hereditary optic atrophy;Optic atrophy;Oscillopsia;Pupillary reflex impaired;Visual evoked potentials abnormal;Visual field defect;Vitamin B12 decreased,105302411,OT,,,,,,,,,105302411,1,HIV infection
10530828,105308281,1,I,20140924,20141015,20141021,20141021,EXP,,ZW-009507513-1410GBR010088,MERCK,,39,YR,,M,Y,,,20141028,N,CN,US,ZW,EFAVIRENZ,Hepatitis,105308281,HO,,,105308281,1,20140818,20141002,,,105308281,1,Antiretroviral therapy
10531209,105312091,1,I,,20141010,20141021,20141021,EXP,,MW-BRISTOL-MYERS SQUIBB COMPANY-21505896,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20141021,N,OT,MW,MW,EFAVIRENZ,Neuropathy peripheral;Osteonecrosis,105312091,OT,,,,,,,,,105312091,1,HIV infection
10531593,105315932,2,F,20140913,20141003,20141021,20141021,EXP,,KE-009507513-1410KEN000218,MERCK,,30,YR,,M,Y,,,20141111,N,CN,KE,KE,EFAVIRENZ,Cerebellar infarction;Cerebral toxoplasmosis;Death;Diarrhoea;Meningitis;Oral candidiasis,105315932,DE,,,105315932,1,20140910,20140927,,,105315932,1,HIV infection
10534658,105346581,1,I,,20141020,20141022,20141022,EXP,,US-BMSGILMSD-2014-0119447,GILEAD,,,,,M,Y,,,20141022,N,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Dementia,105346581,OT,,,,,,,,,105346581,1,HIV infection
10539266,105392661,1,I,,20141010,20141023,20141023,EXP,,MW-MYLANLABS-2014M1008026,MYLAN,"KUDZALA A, CASHMAN J, VAN OOSTERHOUT JJ. CASE REPORT: A MAN ON ANTIRETROVIRAL THERAPY WITH PAINFUL THIGHS. MALAWI-MED-J 2013; 25(1) 24-25",,,,,Y,,,20141023,N,OT,MW,MW,EFAVIRENZ,Osteonecrosis,105392661,HO,,,,,,,,,105392661,1,HIV infection
10540810,105408101,1,I,,20141007,20141022,20141022,EXP,,2014HINLIT0933,HETERO,,33,YR,,M,N,,,20141018,N,OT,ZA,,EFAVIRENZ (EFAVIRENZ),Optic neuropathy,105408101,OT,105408101,HP,,,,,,,105408101,1,HIV infection
10543395,105433951,1,I,,20141014,20141023,20141023,EXP,,2014HINLIT0946,HETERO,,,,,M,N,,,20141021,N,MD,US,,EFAVIRENZ (EFAVIRENZ) UNKNOWN,Drug interaction;Drug resistance;Meningitis viral;Nervous system disorder;Vomiting,105433951,OT,105433951,HP,,,,,,,105433951,1,HIV infection
10543895,105438951,1,I,,20141007,20141023,20141023,EXP,,2014HINLIT0932,HETERO,,31,YR,,M,N,,,20141018,N,MD,ZA,,EFAVIRENZ (EFAVIRENZ),Hereditary optic atrophy,105438951,OT,105438951,HP,,,,,,,105438951,1,HIV infection
10544780,105447801,1,I,20140924,20141015,20141027,20141027,EXP,,ZW-BRISTOL-MYERS SQUIBB COMPANY-21513924,BRISTOL MYERS SQUIBB,,39,YR,,M,Y,,,20141027,N,CN,US,ZW,EFAVIRENZ,Hepatitis,105447801,DE,,,105447801,1,20140818,20141002,,,105447801,1,Antiretroviral therapy
10546087,105460872,2,F,20141004,20141114,20141027,20141118,EXP,,GB-GILEAD-2014-0119488,GILEAD,,46,YR,A,F,Y,64.9,KG,20141118,N,MD,GB,GB,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Intentional overdose,105460872,HO,,,105460872,1,20110802,,,,105460872,1,HIV infection
10548926,105489261,1,I,20130513,20141014,20141028,20141028,EXP,,MY-MYLANLABS-2014M1008126,MYLAN,,,,,,Y,,,20141028,N,OT,MY,MY,EFAVIRENZ,Anaemia;Dizziness;Dyspnoea;Palpitations,105489261,OT,,,,,,,,,105489261,1,Retroviral infection
10553582,105535821,1,I,20140923,20141013,20141028,20141028,EXP,,RUS2014GSK007126,VIIV,,,,,M,N,,,20141024,N,CN,RU,,EFAVIRENZ,Chest pain;Haemoptysis;Pneumonia;Pyrexia;Rales,105535821,OT,105535821,CSM,105535821,1,201406,,,,105535821,1,HIV infection
10554014,105540141,1,I,,20141015,20141030,20141030,EXP,,US-JNJFOC-20141017700,JANSSEN,"HENRICH T, HANHAUSER E, MARTY F, SIRIGNANO M, KEATING S, LEE T. ANTIRETROVIRAL-FREE HIV-1 REMISSION AND VIRAL REBOUND AFTER ALLOGENEIC STEM CELL TRANSPLANTATION. ANNALS OF INTERNAL MEDICNE 2014;161:319-27.",,,,M,Y,,,20141030,N,MD,US,US,EFAVIRENZ,Drug interaction;Headache;Immunosuppressant drug level increased;Nausea;Pyrexia;Renal impairment;Vomiting,105540141,HO,,,,,,,,,105540141,1,Antiviral treatment
10555837,105558371,1,I,,20140807,20141030,20141030,EXP,,ES-GILEAD-2014-0120440,GILEAD,,,,,M,Y,,,20141030,N,MD,ES,ES,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Neuropsychiatric syndrome,105558371,OT,,,105558371,1,200809,,,,105558371,1,HIV infection
10557351,105573512,2,F,,20141110,20141031,20141121,EXP,,US-JNJFOC-20141019629,JANSSEN,,53,YR,A,F,Y,,,20141121,N,OT,US,US,EFAVIRENZ,Drug ineffective;Multiple-drug resistance;Viral mutation identified;Virologic failure,105573512,OT,,,105573512,1,20131028,20140410,,,105573512,1,HIV infection
10558884,105588841,1,I,,20141022,20141101,20141101,EXP,,MW-AUROBINDO-AUR-APL-2014-11371,AUROBINDO,,54,YR,,M,Y,,,20141101,N,OT,MW,MW,Efavirenz,Gait disturbance;Hypoaesthesia;Osteonecrosis;Pain in extremity,105588841,OT,,,,,,,,,105588841,1,HIV infection WHO clinical stage III
10561718,105617181,1,I,,20141021,20141103,20141103,EXP,,FR-GILEAD-2014-0120085,GILEAD,,,,,,Y,,,20141103,N,CN,FR,FR,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Pain in extremity;Weight increased,105617181,OT,,,105617181,1,2011,,,,105617181,1,HIV infection
10561744,105617442,2,F,20141022,20141106,20141103,20141117,EXP,,DE-GILEAD-2014-0120081,GILEAD,,51,YR,A,M,Y,,,20141116,N,MD,DE,DE,SUSTIVA,Acute kidney injury,105617442,OT,,,105617442,1,201409,201410,,,105617442,1,HIV infection
10565609,105656091,1,I,20131019,20141030,20141105,20141105,EXP,,IN-GLAXOSMITHKLINE-IN2014GSK016915,GLAXOSMITHKLINE,PRAMOD KA. CASE REPORT: USE OF HYDROXYCHLOROQUINE IN IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME (IRIS).. 3RD INTERNATIONAL CONFERENCE AND EXHIBITION ON PHARMACOVIGILANCE + CLINICAL TRIA. 2014,26,YR,,F,Y,,,20141105,N,OT,IN,IN,Efavirenz,Cough;Dyspnoea exertional;Headache;Immune reconstitution inflammatory syndrome;Pain;Pyrexia,105656091,OT,,,105656091,1,20130522,,,,105656091,1,Antiretroviral therapy
10566050,105660501,1,I,20140214,,20141104,20141104,DIR,,,,,72,YR,,M,N,97,KG,20140415,N,PH,US,,EFAVIRENZ/EMTRICITABINE/TENOFOVIR,Acute kidney injury,105660501,LT,105660501,HP,105660501,1,20140101,20140214,,,105660501,1,HIV infection
10566381,105663811,1,I,20140813,20141024,20141105,20141105,EXP,,UG-BRISTOL-MYERS SQUIBB COMPANY-21538392,BRISTOL MYERS SQUIBB,,43,YR,,F,Y,52,KG,20141105,N,CN,UG,UG,EFAVIRENZ,Acute kidney injury;Ascites;Decreased appetite;Diarrhoea;Glomerulonephritis;Hepatic cirrhosis;Vomiting,105663811,HO,,,105663811,1,20131211,20140811,,,105663811,1,HIV infection
10567030,105670301,1,I,20141005,20141029,20141105,20141105,EXP,,FR-GILEAD-2014-0121194,GILEAD,,51,YR,A,M,Y,112.5,KG,20141117,N,MD,FR,FR,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Myocardial infarction,105670301,HO,,,105670301,1,20100726,,,,105670301,1,HIV infection
10567034,105670341,1,I,201406,20141021,20141105,20141105,EXP,,FR-BMSGILMSD-2014-0121725,GILEAD,,61,YR,A,M,Y,,,20141105,N,MD,FR,FR,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Acute hepatitis C;Depressed mood;Gastroenteritis;Nausea,105670341,OT,,,105670341,1,20090629,20140930,,,105670341,1,HIV infection
10567093,105670931,1,I,,20140721,20141105,20141105,EXP,,ES-GILEAD-2014-0120405,GILEAD,,54,YR,A,M,Y,,,20141105,N,MD,ES,ES,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Hepatitis C,105670931,OT,,,105670931,1,200803,,,,105670931,1,HIV infection
10567207,105672071,1,I,201309,20141030,20141105,20141105,EXP,,US-BMSGILMSD-2014-0121388,GILEAD,,46,YR,A,F,Y,,,20141105,N,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Leprosy;Pruritus;Pruritus allergic,105672071,OT,,,,,,,,,105672071,1,HIV infection
10568064,105680641,1,I,,20141021,20141104,20141104,EXP,,2014HINLIT0961,HETERO,,54,YR,,M,N,,,20141031,N,OT,MW,,EFAVIRENZ,Drug hypersensitivity;Neuropathy peripheral;Osteonecrosis;Pain in extremity;Rash,105680641,OT,105680641,LIT,,,,,,,105680641,1,Antiretroviral therapy
10569608,105696081,1,I,,20141027,20141106,20141106,EXP,,GH-CIPLA LTD.-2014GH01608,CIPLA,"FRED STEPHEN SARFO,MAAME ANIMA SARFO,BETTY NORMAN,RICHARD PHILLIPS,GEORGE BEDU ADDO,DAVID CHADWICK. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;9:111400",,,A,,Y,,,20141106,N,OT,GH,GH,Efavirenz,Gangrene;Vasculitis,105696081,DE,,,,,,,,,105696081,1,HIV infection
10569651,105696511,1,I,,20141027,20141107,20141107,EXP,,GH-CIPLA LTD.-2014GH01606,CIPLA,"FRED STEPHEN SARFO,MAAME ANIMA SARFO,BETTY NORMAN,RICHARD PHILLIPS,GEORGE BEDU ADDO,DAVID CHADWICK. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;9:111400",,,A,,Y,,,20141107,N,OT,GH,GH,Efavirenz,Systemic candida,105696511,DE,,,,,,,,,105696511,1,HIV infection
10569672,105696721,1,I,,20141027,20141107,20141107,EXP,,GH-CIPLA LTD.-2014GH01609,CIPLA,"FRED STEPHEN SARFO,MAAME ANIMA SARFO,BETTY NORMAN,RICHARD PHILLIPS,GEORGE BEDU ADDO,DAVID CHADWICK. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;9:1114000",,,A,,Y,,,20141107,N,OT,GH,GH,Efavirenz,Pancreatitis,105696721,DE,,,,,,,,,105696721,1,HIV infection
10569676,105696761,1,I,,20141027,20141107,20141107,EXP,,GH-CIPLA LTD.-2014GH01601,CIPLA,"SARFO S, SARFO M, NORMAN B, PHILLIPS R, BEDU-ADDO G, CHADWICK D. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;9:1-12",,,,,Y,,,20141107,N,OT,GH,GH,Efavirenz,Acute abdomen,105696761,DE,,,,,,,,,105696761,2,HIV infection
10569694,105696941,1,I,,20141027,20141107,20141107,EXP,,GH-CIPLA LTD.-2014GH01607,CIPLA,"FRED STEPHEN SARFO,MAAME ANIMA SARFO,BETTY NORMAN,RICHARD PHILLIPS,GEORGE BEDU ADDO,DAVID CHADWICK. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;9:111400",,,,,Y,,,20141107,N,OT,GH,GH,Efavirenz,Intestinal tuberculosis,105696941,DE,,,,,,,,,105696941,1,HIV infection
10569709,105697091,1,I,,20141027,20141107,20141107,EXP,,GH-CIPLA LTD.-2014GH01617,CIPLA,"SARFO FS, SARFO MA, NORMAN B, PHILLIPS R, BEDU-ADDO G, CHADWICK D. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;9:1-12",,,,,Y,,,20141107,N,OT,GH,GH,Efavirenz,Strangulated hernia,105697091,DE,,,,,,,,,105697091,1,HIV infection
10569729,105697291,1,I,,20141027,20141107,20141107,EXP,,GH-CIPLA LTD.-2014GH01619,CIPLA,"SARFO FS, SARFO MA, NORMAN B, PHILLIPS R, BEDU-ADDO G, CHADWICK D. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;9:1-12",,,,,Y,,,20141107,N,OT,GH,GH,Efavirenz,Pneumocystis jirovecii pneumonia,105697291,DE,,,,,,,,,105697291,1,HIV infection
10569749,105697492,2,F,201407,20141204,20141107,20141209,EXP,,FR-ROCHE-1485649,ROCHE,,56,YR,,M,Y,59,KG,20141209,N,MD,FR,FR,SUSTIVA,Anaemia macrocytic;Gastrointestinal haemorrhage;Hepatic cirrhosis;Hepatic encephalopathy,105697492,DE,,,105697492,1,20140207,20140808,,,105697492,1,Hepatitis C
10569782,105697821,1,I,,20141027,20141107,20141107,EXP,,GH-CIPLA LTD.-2014GH01616,CIPLA,"SARFO FS, SARFO MA, NORMAN B, PHILLIPS R, BEDU-ADDO G, CHADWICK D. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;9:1-12",,,,,Y,,,20141107,N,OT,GH,GH,Efavirenz,Hyperosmolar hyperglycaemic state,105697821,DE,,,,,,,,,105697821,1,HIV infection
10569798,105697981,1,I,,20141027,20141107,20141107,EXP,,GH-CIPLA LTD.-2014GH01604,CIPLA,"SARFO S, SARFO M, NORMAN B, PHILLIPS R, BEDU-ADDO G, CHADWICK D. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;9:1-12",,,,,Y,,,20141107,N,OT,GH,GH,Efavirenz,Cervix carcinoma,105697981,OT,,,,,,,,,105697981,1,HIV infection
10569849,105698491,1,I,,20141027,20141107,20141107,EXP,,GH-CIPLA LTD.-2014GH01618,CIPLA,"SARFO FS, SARFO MA, NORMAN B, PHILLIPS R, BEDU-ADDO G, CHADWICK D. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;9:1-12",,,,,Y,,,20141107,N,OT,GH,GH,Efavirenz,Otitis media,105698491,DE,,,,,,,,,105698491,1,HIV infection
10573021,105730211,1,I,20131019,20141030,20141106,20141106,EXP,,IN2014GSK016915,VIIV,,26,YR,,F,N,,,20141105,N,OT,IN,,EFAVIRENZ (EFAVIRENZ) UNKNOWN,Headache;Immune reconstitution inflammatory syndrome associated tuberculosis;Pain,105730211,HO,105730211,LIT,105730211,1,20130522,,,,105730211,1,Antiretroviral therapy
10573846,105738461,1,I,,20141027,20141110,20141110,EXP,,GH-CIPLA LTD.-2014GH01602,CIPLA,"SARFO F, SARFO M, NORMAN B, PHILLIPS R, BEDU-ADDO G, CHADWICK D. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;9:1-12",,,,,Y,,,20141110,N,OT,GH,GH,Efavirenz,Hepatic amoebiasis,105738461,DE,,,,,,,,,105738461,1,HIV infection
10574892,105748921,1,I,,20141027,20141110,20141110,EXP,,GH-CIPLA LTD.-2014GH01603,CIPLA,"SARFO S, SARFO M, NORMAN B, PHILLIPS R, BEDU-ADDO G, CHADWICK D. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;9:1-12",,,,,Y,,,20141111,N,OT,GH,GH,Efavirenz,Lymphoma,105748921,DE,,,,,,,,,105748921,1,HIV infection
10574918,105749181,1,I,,20141027,20141110,20141110,EXP,,GH-CIPLA LTD.-2014GH01613,CIPLA,"FRED STEPHEN SARFO,MAAME ANIMA SARFO,BETTY NORMAN,RICHARD PHILLIPS,GEORGE BEDU ADDO,DAVID CHADWICK. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;09:10-12",,,,,Y,,,20141111,N,OT,GH,GH,Efavirenz,Hepatitis B,105749181,DE,,,,,,,,,105749181,1,Antiretroviral therapy
10574931,105749311,1,I,,20141027,20141110,20141110,EXP,,GH-CIPLA LTD.-2014GH01611,CIPLA,"FRED STEPHEN SARFO,MAAME ANIMA SARFO,BETTY NORMAN,RICHARD PHILLIPS,GEORGE BEDU ADDO,DAVID CHADWICK. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;9:E1114000",,,A,,Y,,,20141111,N,OT,GH,GH,Efavirenz,Subcutaneous abscess,105749311,DE,,,,,,,,,105749311,1,Antiretroviral therapy
10574935,105749351,1,I,,20141027,20141110,20141110,EXP,,GH-CIPLA LTD.-2014GH01612,CIPLA,"FRED STEPHEN SARFO,MAAME ANIMA SARFO,BETTY NORMAN,RICHARD PHILLIPS,GEORGE BEDU ADDO,DAVID CHADWICK. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;09:1-12",,,,,Y,,,20141111,N,OT,GH,GH,Efavirenz,Hepatocellular carcinoma,105749351,DE,,,,,,,,,105749351,1,Antiretroviral therapy
10574941,105749411,1,I,,20141027,20141110,20141110,EXP,,GH-CIPLA LTD.-2014GH01614,CIPLA,"FRED STEPHEN SARFO,MAAME ANIMA SARFO,BETTY NORMAN,RICHARD PHILLIPS,GEORGE BEDU ADDO,DAVID CHADWICK. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;09:1-12",,,A,,Y,,,20141111,N,OT,GH,GH,Efavirenz,Non-Hodgkin's lymphoma,105749411,DE,,,,,,,,,105749411,1,Antiretroviral therapy
10574998,105749981,1,I,,20141027,20141111,20141111,EXP,,GH-CIPLA LTD.-2014GH01622,CIPLA,"FRED STEPHEN SARFO,MAAME ANIMA SARFO,BETTY NORMAN,RICHARD PHILLIPS,GEORGE BEDU ADDO,DAVID CHADWICK. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;9:0111400",,,,,Y,,,20141111,N,OT,GH,GH,Efavirenz,Meningitis cryptococcal,105749981,OT,,,,,,,,,105749981,1,HIV infection
10575000,105750001,1,I,,20141027,20141111,20141111,EXP,,GH-CIPLA LTD.-2014GH01623,CIPLA,"FRED STEPHEN SARFO,MAAME ANIMA SARFO,BETTY NORMAN,RICHARD PHILLIPS,GEORGE BEDU ADDO,DAVID CHADWICK. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;9:0111400",,,,,Y,,,20141111,N,OT,GH,GH,Efavirenz,Oesophageal carcinoma,105750001,OT,,,,,,,,,105750001,1,HIV infection
10575060,105750601,1,I,,20141027,20141111,20141111,EXP,,GH-CIPLA LTD.-2014GH01624,CIPLA,"FRED STEPHEN SARFO,MAAME ANIMA SARFO,BETTY NORMAN,RICHARD PHILLIPS,GEORGE BEDU ADDO,DAVID CHADWICK. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;9:0111400",,,,,Y,,,20141111,N,OT,GH,GH,Efavirenz,Lymphoma,105750601,OT,,,,,,,,,105750601,1,HIV infection
10575068,105750681,1,I,,20141027,20141111,20141111,EXP,,GH-CIPLA LTD.-2014GH01625,CIPLA,"FRED STEPHEN SARFO,MAAME ANIMA SARFO,BETTY NORMAN,RICHARD PHILLIPS,GEORGE BEDU ADDO,DAVID CHADWICK. RISK OF DEATHS, AIDS-DEFINING AND NON-AIDS DEFINING EVENTS AMONG GHANAIANS ON LONG-TERM COMBINATION ANTIRETROVIRAL THERAPY. PLOS ONE. 2014;9:0111400",,,,,Y,,,20141111,N,OT,GH,GH,Efavirenz,Herpes oesophagitis,105750681,OT,,,,,,,,,105750681,1,HIV infection
10580358,105803581,1,I,20141017,20141103,20141112,20141112,EXP,,BW-GILEAD-2014-0122055,GILEAD,,32,YR,A,F,Y,,,20141112,N,MD,BW,BW,EFAVIRENZ,Menorrhagia,105803581,HO,,,105803581,1,20110624,20140806,,,105803581,1,HIV infection
10583248,105832481,1,I,20140822,20141029,20141114,20141114,EXP,,ZW-BRISTOL-MYERS SQUIBB COMPANY-21563655,BRISTOL MYERS SQUIBB,,34,YR,,F,Y,48,KG,20141113,N,CN,US,ZW,EFAVIRENZ,Haemangioma;Meningitis,105832481,HO,,,105832481,1,20140331,,,,105832481,1,HIV infection
10585081,105850811,1,I,20140930,20141104,20141113,20141113,EXP,,US2014GSK010116,VIIV,,48,YR,,M,N,,,20141110,N,MD,US,,EFAVIRENZ,Adverse drug reaction;Drug administration error;Drug ineffective;Drug interaction;Hospitalisation,105850811,HO,105850811,HP,105850811,1,201002,20141004,,,105850811,1,HIV infection
10585920,105859202,2,F,201407,20141205,20141114,20141212,EXP,FR-ANSM-PB20141050,FR-GILEAD-2014-0121927,GILEAD,,56,YR,A,M,Y,54,KG,20141212,N,OT,FR,FR,SUSTIVA,Anaemia macrocytic;Gastrointestinal haemorrhage;Hepatic cirrhosis;Hepatic encephalopathy,105859202,DE,,,105859202,1,20140207,20140808,,,105859202,1,Hepatitis C
10586841,105868412,2,F,20140522,20141103,20141117,20141117,EXP,GB-MHRA-EYC 00111721,GB-GLENMARK GENERICS INC.-2014GMK009749,GLENMARK,,51,YR,,M,Y,,,20141117,N,MD,GB,GB,EFAVIRENZ,Chest pain;Paraesthesia;Vomiting,105868412,HO,,,105868412,1,20140501,20140526,,,105868412,1,Product used for unknown indication
10588523,105885231,1,I,20140522,20141103,20141117,20141117,EXP,,GB-WATSON-2014-24329,WATSON,,51,YR,,M,Y,,,20141117,N,CN,GR,GB,EFAVIRENZ,Chest pain;Paraesthesia;Vomiting,105885231,HO,,,105885231,1,20140501,20140526,,,105885231,1,Product used for unknown indication
10588613,105886132,2,F,20140815,20141120,20141117,20141125,EXP,,ZW-GILEAD-2014-0122190,GILEAD,,49,YR,A,M,Y,,,20141125,N,MD,ZW,ZW,EFAVIRENZ,Death;Headache,105886132,DE,,,105886132,1,20131017,,,,105886132,1,HIV infection
10588668,105886681,1,I,,20141106,20141117,20141117,EXP,,US-BMSGILMSD-2014-0122706,GILEAD,,60,YR,A,,Y,,,20141117,N,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Osteoporosis,105886681,OT,,,,,,,,,105886681,1,Product used for unknown indication
10588774,105887741,1,I,,20141106,20141117,20141117,EXP,,US-BMSGILMSD-2014-0122812,GILEAD,,,,A,,Y,,,20141117,N,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Osteoporosis,105887741,OT,,,105887741,1,2011,,,,105887741,1,HIV infection
10589464,105894641,1,I,,20141107,20141118,20141118,EXP,,NL-CIPLA LTD.-2014NL01963,CIPLA,"ROKX C, FIBRIANI A, VAN DE VIJVER D, VERBON A, SCHUTTEN M, GRAS L, RIJNDERS B. INCREASED VIROLOGICAL FAILURE IN NAIVE HIV-1-INFECTED PATIENTS TAKING LAMIVUDINE COMPARED WITH EMTRICITABINE IN COMBINATION WITH TENOFOVIR AND EFAVIRENZ OR NEVIRAPINE IN THE DUTCH NATIONWIDE ATHENA COHORT. HIV/AIDS. 2014",,,,,Y,,,20141119,N,MD,NL,NL,Efavirenz,Virologic failure,105894641,OT,,,,,,,,,105894641,1,HIV infection
10589483,105894833,3,F,20141025,20141215,20141114,20141223,EXP,,US2014GSK019874,VIIV,,64,YR,,M,N,59.0,KG,20141219,N,OT,US,,EFAVIRENZ,Eye movement disorder;Seizure;Syncope;Tremor,105894833,OT,105894833,HP,105894833,1,20141004,20141027,,,105894833,1,HIV infection
10590780,105907801,1,I,2014,20141103,20141118,20141118,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-21570429,BRISTOL MYERS SQUIBB,,39,YR,,M,Y,80,KG,20141118,N,CN,US,IT,EFAVIRENZ,Acute respiratory failure;Pneumonia aspiration,105907801,LT,,,105907801,1,20130227,,,,105907801,1,HIV infection
10591095,105910952,2,F,,20141111,20141118,20141120,EXP,,IL-GILEAD-2014-0122673,GILEAD,,,,,,Y,,,20141120,N,OT,IL,IL,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Diaphragmatic hernia;Gastrointestinal disorder,105910952,CA,,,105910952,1,20140506,20140619,,,105910952,1,HIV infection
10591369,105913691,1,I,,20141113,20141118,20141118,EXP,,US-GILEAD-2014-0123016,GILEAD,,66,YR,E,M,Y,,,20141118,N,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Chemotherapy,105913691,OT,,,,,,,,,105913691,1,HIV infection
10592058,105920581,1,I,,20141107,20141119,20141119,EXP,,NL-CIPLA LTD.-2014NL01964,CIPLA,"ROKX C, FIBRIANI A, DAVID A. M. C.,VIJVER VD,VERBON A,SCHUTTEN M,GRAS L,RIJNDERS BJA. INCREASED VIROLOGICAL FAILURE IN NAIVE HIV 1 INFECTED PATIENTS TAKING LAMIVUDINE COMPARED WITH EMTRICITABINE IN COMBINATION WITH TENOFOVIR AND EFAVIRENZ OR NEVIRAPINE IN THE DUTCH NATIONWIDE ATHENA COHORT. HIV/AIDS. 2014;1-11",,,,,Y,,,20141119,N,OT,NL,NL,Efavirenz,Gene mutation;Virologic failure,105920581,OT,,,,,,,,,105920581,1,HIV infection
10592332,105923321,1,I,20140501,20141106,20141117,20141117,EXP,,UG2014GSK021125,VIIV,,36,YR,,M,N,,,20141114,N,MD,UG,,EFAVIRENZ,Anaemia;Pulmonary tuberculosis;Tuberculosis,105923321,HO,105923321,SDY,105923321,1,20140507,20140605,,,105923321,1,HIV infection
10592382,105923821,1,I,,20141107,20141119,20141119,EXP,,NL-CIPLA LTD.-2014NL01965,CIPLA,"ROKX C, FIBRIANI A, DAVID A. M. C.,VIJVER VD,VERBON A,SCHUTTEN M,GRAS L,RIJNDERS BJA,. INCREASED VIROLOGICAL FAILURE IN NAIVE HIV 1 INFECTED PATIENTS TAKING LAMIVUDINE COMPARED WITH EMTRICITABINE IN COMBINATION WITH TENOFOVIR AND EFAVIRENZ OR NEVIRAPINE IN THE DUTCH NATIONWIDE ATHENA COHORT. HIV/AIDS. 2014;1 TO 11",,,A,,Y,,,20141119,N,OT,NL,NL,Efavirenz,Gene mutation;Virologic failure,105923821,OT,,,,,,,,,105923821,1,HIV infection
10592752,105927521,1,I,,20141107,20141119,20141119,EXP,,NL-CIPLA LTD.-2014NL01966,CIPLA,"CASPER ROKX,  AZANIA FIBRIANI ,  DAVID A. M. C. VAN DE VIJVER,  ANNELIES VERBON, MARTIN SCHUTTEN,  LUUK GRAS, AND BART J. A. RIJNDERS. INCREASED VIROLOGICAL FAILURE IN NAIVE HIV 1 INFECTED PATIENTS TAKING LAMIVUDINE COMPARED WITH EMTRICITABINE IN COMBINATION WITH TENOFOVIR AND EFAVIRENZ OR NEVIRAPINE IN THE DUTCH NATIONWIDE ATHENA COHORT. HIV/AIDS. 2014;01 TO 11",,,,,Y,,,20141119,N,OT,NL,NL,Efavirenz,Gene mutation;Virologic failure,105927521,OT,,,,,,,,,105927521,1,HIV infection
10592816,105928161,1,I,,20141107,20141119,20141119,EXP,,NL-CIPLA LTD.-2014NL01973,CIPLA,"ROKX C, FIBRIANI A, VAN DE VIJVER D, VERBON A, SCHUTTEN M, GRAS L ET.AL.. INCREASED VIROLOGICAL FAILURE IN NAIVE HIV-1 INFECTED PATIENTS TAKING LAMIVUDINE COMPARED WITH EMTRICITABINE IN COMBINATION WITH TENOFOVIR AND EFAVIRENZ OR NEVIRAPINE IN THE DUTCH NATIONWIDE ATHENA COHORT. CLINICAL INFECTIOUS DISEASES. 2014",,,,,Y,,,20141119,N,OT,NL,NL,Efavirenz,Gene mutation;Virologic failure,105928161,OT,,,,,,,,,105928161,1,HIV infection
10594047,105940471,1,I,,20141111,20141119,20141119,EXP,,RO-GLAXOSMITHKLINE-RO2014GSK021254,GLAXOSMITHKLINE,"DUPONT I, RADULESCU MA, ARAMA V. THERAPEUTIC DIFFICULTIES IN A PATIENT WITH HIV INFECTION AND PLEURAL TUBERCULOSIS. PHARMACEUTICA PRACTICE. 2014;7(3)",41,YR,,F,Y,,,20141119,N,MD,RO,RO,Efavirenz,Anaemia;Hepatitis cholestatic;Immune reconstitution inflammatory syndrome;Lymphadenopathy mediastinal;Metabolic acidosis;Pleurisy;Renal impairment;Transaminases abnormal;Tuberculosis,105940471,HO,105940471,LIT,105940471,1,2011,,,,105940471,1,HIV infection
10594549,105945491,1,I,,20141107,20141120,20141120,EXP,,NL-CIPLA LTD.-2014NL01962,CIPLA,"ROKX C, FIBRIANI A, DAVID A. M. C.,VIJVER VD,VERBON A,SCHUTTEN M,GRAS L,RIJNDERS BJA. INCREASED VIROLOGICAL FAILURE IN NAIVE HIV 1 INFECTED PATIENTS TAKING LAMIVUDINE COMPARED WITH EMTRICITABINE IN COMBINATION WITH TENOFOVIR AND EFAVIRENZ OR NEVIRAPINE IN THE DUTCH NATIONWIDE ATHENA COHORT. HIV/AIDS. 2014",,,A,M,Y,,,20141120,N,OT,NL,NL,Efavirenz,Gene mutation;Virologic failure,105945491,OT,,,,,,,,,105945491,1,HIV infection
10594591,105945911,1,I,,20141107,20141120,20141120,EXP,,NL-CIPLA LTD.-2014NL01972,CIPLA,"CASPER ROKX,  AZANIA FIBRIANI ,  DAVID A. M. C. VAN DE VIJVER,  ANNELIES VERBON, MARTIN SCHUTTEN,  LUUK GRAS AND BART J. A. RIJNDERS. INCREASED VIROLOGICAL FAILURE IN NAIVE HIV 1 INFECTED PATIENTS TAKING LAMIVUDINE COMPARED WITH EMTRICITABINE IN COMBINATION WITH TENOFOVIR AND EFAVIRENZ OR NEVIRAPINE IN THE DUTCH NATIONWIDE ATHENA COHORT. HIV/AIDS. 2014;01 TO 11",,,,,Y,,,20141120,N,OT,NL,NL,Efavirenz,Gene mutation;Virologic failure,105945911,OT,,,,,,,,,105945911,1,HIV infection
10596382,105963821,1,I,200905,20141107,20141120,20141120,EXP,,IT-MYLANLABS-2014M1011210,MYLAN,"DURANTE-MANGONI E, MAIELLO C, LIMONGELLI G, SBREGLIA C, PINTO D, AMARELLI C, ET AL. MANAGEMENT OF IMMUNOSUPPRESSION AND ANTIVIRAL TREATMENT BEFORE AND AFTER HEART TRANSPLANT FOR HIV-ASSOCIATED DILATED CARDIOMYOPATHY. INT-J-IMMUNOPATHOL-PHARMACOL 2014; 27(1) 113-120",,,,,Y,,,20141120,N,MD,IT,IT,EFAVIRENZ,Bundle branch block left;Cardiac failure;Congestive cardiomyopathy;Mitral valve incompetence;Ventricular extrasystoles,105963821,HO,,,105963821,1,200502,,,,105963821,1,HIV infection
10600390,106003901,1,I,,20141110,20141124,20141124,EXP,,GH-CIPLA LTD.-2014GH02047,CIPLA,"FRED STEPHEN SARFO, ADETAYO KASIM, RICHARD PHILLIPS, ANNA MARIA GERETTI, DAVID R. CHADWICK. LONG-TERM RESPONSES TO FIRST-LINE ANTIRETROVIRAL THERAPY IN HIV AND HEPATITIS B CO-INFECTION IN GHANA. JOURNAL OF INFECTION. 2014;69:481-489",,,,,Y,,,20141124,N,OT,GH,GH,Efavirenz,Hepatocellular carcinoma,106003901,DE,,,,,,,,,106003901,1,HIV infection
10600792,106007921,1,I,200605,20141110,20141124,20141124,EXP,,IT-CIPLA LTD.-2014IT01982,CIPLA,"CHESSA L, ONALI S, FIGORILLI F, BALESTRIERI C, SERRA G, CONTI M ET.AL.. CAN ANTIRETEROVIRAL THERAPY MODIFY THE CLINICAL COURSE OF HDV INFECTION IN HIV POSITIVE PATIENTS. ANTIRETEROVIRAL THERAPY. 2014",,,,,Y,,,20141124,N,OT,IT,IT,Efavirenz,Lipodystrophy acquired,106007921,OT,,,106007921,1,200412,200605,,,106007921,1,Antiretroviral therapy
10601562,106015622,2,F,20140701,20141106,20141124,20141124,EXP,,ZW-009507513-1407ZWE009199,MERCK,,32,YR,,F,Y,,,20141124,N,CN,US,ZW,EFAVIRENZ,Anaemia;Gastroenteritis;Immune reconstitution inflammatory syndrome;Meningitis;Pulmonary tuberculosis,106015622,HO,,,106015622,1,20140630,20140922,,,106015622,1,Antiretroviral therapy
10602050,106020502,2,F,20141013,20141208,20141124,20141222,EXP,,UG-009507513-1411UGA010315,MERCK,,39,YR,,M,Y,,,20141222,N,CN,UG,UG,EFAVIRENZ,Mycobacterium test positive;Tuberculosis,106020502,HO,,,106020502,1,20141008,20141012,,,106020502,1,HIV infection
10602200,106022001,1,I,,20141113,20141120,20141120,EXP,,JP2014JPN021457,VIIV,,,,,,N,,,20141119,N,PH,JP,,STOCRIN (EFAVIRENZ) TABLET,Drug effect incomplete;Renal impairment,106022001,OT,106022001,FGN,,,,,,,106022001,1,HIV infection
10602216,106022161,1,I,,20141111,20141120,20141120,EXP,,RO2014GSK021254,VIIV,,41,YR,,F,N,,,20141119,N,,RO,,EFAVIRENZ (EFAVIRENZ) UNKNOWN,Anaemia;Hepatitis cholestatic;Immune reconstitution inflammatory syndrome;Lymphadenopathy mediastinal;Metabolic acidosis;Pleurisy;Renal impairment;Transaminases abnormal;Tuberculosis,106022161,OT,106022161,HP,106022161,1,2011,,,,106022161,1,HIV infection
10608174,106081741,1,I,,20141114,20141125,20141125,EXP,,IN-MYLANLABS-2014M1011824,MYLAN,"SINGH S, SHARMA T, RAI T, PRABHU A. TYPE 2 LEPRA REACTION IN AN IMMUNOCOMPROMISED PATIENT PRECIPITATED BY FILARIASIS. INDIAN-J-SEX-TRANSM-DIS 2014; 35(1) 40-42",,,,,Y,,,20141125,N,OT,IN,IN,EFAVIRENZ,Bone marrow failure,106081741,OT,,,,,,,,,106081741,1,Antiretroviral therapy
10611041,106110412,2,F,,20141114,20141126,20141126,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-21625264,BRISTOL MYERS SQUIBB,,55,YR,,M,Y,,,20141126,N,CN,FR,FR,SUSTIVA,Psychiatric symptom,106110412,OT,,,106110412,1,20060602,20071210,,,106110412,1,HIV infection
10611342,106113422,2,F,20131123,20141120,20141126,20141126,EXP,,KE-GLAXOSMITHKLINE-B0950259A,GLAXOSMITHKLINE,,45,YR,,M,Y,,,20141126,N,MD,KE,KE,Efavirenz,Death,106113422,OT,,,106113422,1,20131017,20131123,,,106113422,1,HIV infection
10613494,106134941,1,I,,20141117,20141128,20141128,EXP,,IN-ROCHE-1491915,ROCHE,"SOANKER R, UDUTHA S, SUBBALAXMI M AND RAJU Y. GANCICLOVIR-TENOFOVIR INTERACTION LEADING TO TENOFOVIR-INDUCED NEPHROTOXICITY. JOURNAL OF PHARMACOLOGY AND PHARMACOTHERAPEUTICS 2014 OCT 01;5 (4):265-267.",51,YR,,F,Y,,,20141128,N,OT,IN,IN,EFAVIRENZ,Drug interaction;Nephropathy toxic,106134941,HO,,,,,,,,,106134941,1,Decreased appetite
10615234,106152341,1,I,,20141117,20141201,20141201,EXP,,IT-CIPLA LTD.-2014IT02251,CIPLA,"CALZA L, DANESE I, COLANGELI V, VANDI G, MANFREDI R, GIROMETTI N, BORDERI M, APPOLLONI L, PUGGIOLI C, VIALE P. SKELETAL MUSCLE TOXICITY IN HIV 1 INFECTED PATIENTS TREATED WITH A RALTEGRAVIR-CONTAINING ANTIRETROVIRAL THERAPY:A COHORT STUDY. AIDS RESEARCH AND HUMAN RETROVIRUSES. 2014;30",,,,,Y,,,20141201,N,OT,IT,IT,Efavirenz,Muscular weakness,106152341,OT,,,,,,,,,106152341,1,HIV infection
10615235,106152351,1,I,,20141117,20141201,20141201,EXP,,ES-CIPLA LTD.-2014ES02244,CIPLA,"ASPIROZ EL,FIGUEROA SC, GOMEZ AI, MERINO MV, HURLE AG. CYP3A4 POLYMORPHISM AND LOPINAVIR TOXICITY IN AN HIV INFECTED PREGNANT WOMAN. CLIN DRUG INVESTIG. 2014",37,YR,,F,Y,,,20141201,N,OT,ES,ES,Efavirenz,Diarrhoea;Drug resistance;Exposure during pregnancy;Gastrointestinal disorder;Haematology test abnormal;Lipids increased;Meningitis aseptic;Poisoning,106152351,HO,,,,,,,,,106152351,1,HIV infection
10619951,106199511,1,I,20131123,20141120,20141128,20141128,EXP,,B0950259A,VIIV,,45,YR,,M,N,,,20141126,N,MD,KE,,EFAVIRENZ (EFAVIRENZ) UNKNOWN,Death,106199511,DE,106199511,FGN,106199511,1,20131017,20131123,,,106199511,1,HIV infection
10622158,106221581,1,I,20141007,,20141201,20141201,DIR,,,,,61,YR,,M,N,97.3,KG,20141030,N,PH,US,,EFAVIRENZ/EMTRICITABINE/TENOFOVIR,Lipodystrophy acquired,106221581,HO,106221581,HP,106221581,1,20080712,,,,106221581,1,Infection
10624864,106248641,1,I,20131005,20141121,20141204,20141204,EXP,,ZW-BRISTOL-MYERS SQUIBB COMPANY-21640198,BRISTOL MYERS SQUIBB,,45,YR,,M,Y,41.8,KG,20141204,N,CN,ZW,ZW,EFAVIRENZ,Death;Decreased appetite;Dehydration;Diarrhoea;Weight decreased,106248641,DE,,,106248641,1,20130910,,,,,,
10624899,106248992,2,F,,20141212,20141204,20141223,EXP,,GB-AUROBINDO-AUR-APL-2014-12710,AUROBINDO,,11,YR,,F,Y,,,20141223,N,MD,GB,GB,Efavirenz,Aphasia;Arterial wall hypertrophy;Carotid artery occlusion;Cerebral infarction;Cerebrovascular accident;Hemiplegia;Immune reconstitution inflammatory syndrome;VIIth nerve paralysis;Vascular stenosis,106248992,HO,,,,,,,,,106248992,1,Antiretroviral therapy
10625110,106251101,1,I,20140307,20141119,20141202,20141202,EXP,,B0982220A,VIIV,,32,YR,,M,N,68,KG,20141127,N,MD,ES,,EFAVIRENZ,Non-Hodgkin's lymphoma,106251101,RI,106251101,HP,106251101,1,20130723,20140321,,,106251101,1,HIV infection
10625177,106251771,1,I,,20141124,20141202,20141202,EXP,,US2014GSK027863,VIIV,,51,YR,,M,N,,,20141127,N,MD,US,,EFAVIRENZ (EFAVIRENZ),Eyelid ptosis;Mitochondrial myopathy,106251771,OT,106251771,LIT,,,,,,,106251771,1,HIV infection
10626324,106263241,1,I,,20141125,20141204,20141204,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-21660618,BRISTOL MYERS SQUIBB,,51,YR,,M,Y,,,20141204,N,OT,US,US,SUSTIVA,Eyelid ptosis;Mitochondrial myopathy,106263241,OT,,,,,,,,,106263241,1,HIV infection
10626920,106269202,2,F,200509,20141210,20141204,20141211,EXP,,IN-MYLANLABS-2014M1012780,MYLAN,"DUTTA N, DE R, MUKHERJEE P, BHOWMIK A, MODOK D, GUHA SK. A CASE OF RAPID SECOND-LINE ANTI-RETROVIRAL TREATMENT FAILURE: AN ANALYSIS OF POSSIBLE CAUSES AND PREVENTIVES. J-INDIAN-ACAD-CLIN-MED 2014; 15 229-231",,,A,M,Y,,,20141211,N,OT,IN,IN,EFAVIRENZ,Anaemia;Gastritis;Treatment failure,106269202,OT,,,106269202,1,200708,200911,,,106269202,1,HIV infection
10627413,106274131,1,I,,20141121,20141205,20141205,EXP,,GB-MYLANLABS-2014M1012373,MYLAN,"IRO MA, KIRKHAM FJ, MACDONALD JHM, TEBRUEGGE M, FAUST SN, PATEL SV. VARICELLA ZOSTER VIRUS CENTRAL NERVOUS SYSTEM IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME PRESENTING IN A CHILD. PEDIATR-INFECT-DIS-J 2013; 32(11) 1283-1284",,,,,Y,,,20141205,N,OT,GB,GB,EFAVIRENZ,Cerebrovascular accident;Immune reconstitution inflammatory syndrome;Varicella virus test positive,106274131,HO,,,,,,,,,106274131,1,HIV infection CDC Group III
10628340,106283401,1,I,201407,20140807,20141205,20141205,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-21297437,BRISTOL MYERS SQUIBB,,48,YR,A,F,Y,,,20141204,N,CN,US,US,SUSTIVA,Insomnia;Palpitations;Restlessness,,,,,,,,,,,106283401,1,Schizophrenia
10628978,106289781,1,I,,20140829,20141205,20141205,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-21352471,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20141204,N,CN,US,US,SUSTIVA,Collagen disorder,,,,,,,,,,,,,
10629061,106290611,1,I,2014,20141112,20141205,20141205,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-21601083,BRISTOL MYERS SQUIBB,,44,YR,A,F,Y,,,20141204,N,CN,US,US,SUSTIVA,Erythema;Scratch,,,,,,,,,,,106290611,1,HIV test
10629489,106294891,1,I,20131007,20140616,20141205,20141205,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-21154208,BRISTOL MYERS SQUIBB,,31,YR,,F,Y,,,20141204,N,CN,US,US,EFAVIRENZ TABS,Normal newborn;Pregnancy,,,,,,,,,,,106294891,1,Antiretroviral therapy
10629490,106294901,1,I,,20140709,20141205,20141205,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-21192372,BRISTOL MYERS SQUIBB,,,,,,Y,,,20141204,N,PH,US,US,SUSTIVA TABS,Dysphagia;Gastrointestinal tube insertion,,,,,,,,,,,,,
10635697,106356971,1,I,20141118,20141202,20141205,20141205,EXP,,VN-GILEAD-2014-0125538,GILEAD,,36,YR,A,M,Y,,,20141205,N,MD,VN,VN,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Appendicitis,106356971,OT,,,106356971,1,20141110,,,,106356971,1,HIV infection
10637006,106370062,2,F,201411,20141210,20141208,20141217,EXP,,GB-AUROBINDO-AUR-APL-2014-12727,AUROBINDO,,21,YR,,M,Y,68,KG,20141217,N,MD,GB,GB,EFAVIRENZ,Hypoglycaemia;Intentional overdose,106370062,LT,,,106370062,2,20140801,201411,,,106370062,1,Depression
10639370,106393701,1,I,201411,20141202,20141208,20141208,EXP,GB-MHRA-EYC 00117470,GB-GILEAD-2014-0125274,GILEAD,,21,YR,A,M,Y,68,KG,20141208,N,MD,GB,GB,EFAVIRENZ,Hypoglycaemia;Intentional overdose,106393701,LT,,,106393701,1,20140801,201411,,,106393701,1,HIV infection
10641447,106414471,1,I,,20141202,20141208,20141208,EXP,,FK201405803,FRESENIUS MEDICAL CARE,,51,YR,,F,N,,,20141204,N,OT,IN,,EFAVIRENZ (EFAVIRENZ),Acute kidney injury;Blood glucose decreased;Cerebral atrophy;Drug interaction;Heart rate increased;Hypophagia;Metabolic acidosis;Pallor;Vomiting,106414471,HO,106414471,HP,106414471,2,,,5,YR,106414471,1,Decreased appetite
10641942,106419421,1,I,,20141202,20141209,20141209,EXP,,US-BMSGILMSD-2014-0125491,GILEAD,,45,YR,A,M,Y,,,20141209,N,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Cognitive disorder,106419421,OT,,,,,,,,,106419421,1,HIV infection
10643502,106435022,2,F,,20141202,20141210,20141210,EXP,,US-ABBVIE-10P-163-0641882-00,ABBVIE,,52,YR,,M,Y,,,20141210,N,OT,US,US,SUSTIVA,Diplopia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Progressive external ophthalmoplegia,106435022,OT,,,,,,,,,106435022,1,Product used for unknown indication
10644733,106447331,1,I,,20141203,20141211,20141211,EXP,,US-CIPLA LTD.-2014US02339,CIPLA,"HAVLIR DV, COHAN D, NATUREEBA P, KOSS CA, PLENTY A, LUWEDDE F ET.AL.. EFFICACY AND SAFETY OF LOPINAVIR/RITONAVIR VERSUS EFAVIRENZ-BASED ANTIRETROVIRAL THERAPY IN HIV-INFECTED PREGNANT UGANDAN WOMEN. AIDS. 2014;28:1-9",,,,,Y,,,20141211,N,OT,US,US,Efavirenz,Kaposi's sarcoma,106447331,OT,,,,,,,,,106447331,1,HIV infection
10647601,106476011,1,I,,20141205,20141211,20141211,EXP,,US-BMSGILMSD-2014-0126341,GILEAD,,44,YR,A,M,Y,,,20141211,N,OT,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Lymphoma,106476011,HO,,,,,,,,,106476011,1,Product used for unknown indication
10651768,106517681,1,I,,20141201,20141211,20141211,EXP,,20140776,LUITPOLD,,35,YR,,F,N,32,KG,20141208,N,OT,CH,,SUSTIVA (EFAVIRENZ),Depression;Herpes virus infection;Hypophagia;Simplex virus test positive,106517681,HO,106517681,FGN,,,,,,,106517681,1,Anaemia
10651828,106518281,1,I,,20141125,20141211,20141211,EXP,,2014HINLIT1030,HETERO,,35,YR,,M,N,,,20141206,N,OT,IN,,EFAVIRENZ (EFAVIENZ),Acquired immunodeficiency syndrome;Anaemia;Arthralgia;Bone marrow failure;Cachexia;Filariasis;Haematotoxicity;Hypoaesthesia;Lepromatous leprosy;Lymph node tuberculosis;Rash erythematous,106518281,OT,106518281,FGN,,,,,,,106518281,1,HIV infection
10651845,106518451,1,I,,20141125,20141211,20141211,EXP,,2014HINLIT1043,HETERO,,11,YR,,F,N,,,20141204,N,MD,GB,,EFAVIRENZ,Aphasia;Hemiplegia;Herpes zoster;Immune reconstitution inflammatory syndrome;VIIth nerve paralysis,106518451,HO,106518451,LIT,,,,,,,106518451,1,Antiretroviral therapy
10652607,106526071,1,I,20141123,20141202,20141215,20141215,EXP,GB-MHRA-EYC 00117470,GB-WATSON-2014-26360,WATSON,,21,YR,,M,Y,68,KG,20141215,N,CN,GB,GB,Efavirenz (Unknown),Hypoglycaemia;Overdose,106526071,LT,,,106526071,2,20140801,,,,106526071,1,Depression
10659234,106592341,1,I,,20141210,20141217,20141217,EXP,,"IN-ROXANE LABORATORIES, INC.-2014-RO-01887RO",ROXANE,"SINGH S,SHARMA T,RAI T,PRABHU A. TYPE 2 LEPRA REACTION IN AN IMMUNOCOMPROMISED PATIENT PRECIPITATED BY FILARIASIS. INDIAN JOURNAL OF SEXUALLY TRANSMITTED DISEASES 2014 JAN;35:1:40-42.",35,YR,,M,Y,,,20141217,N,OT,COUNTRY NOT SPECIFIED,IN,EFAVIRENZ,Filariasis;Type 2 lepra reaction,106592341,OT,,,,,,,,,106592341,1,Antiretroviral therapy
10660054,106600542,2,F,20141106,20141211,20141217,20141217,EXP,,FR-GLAXOSMITHKLINE-FR2014GSK018422,GLAXOSMITHKLINE,,9,YR,,F,Y,28.3,KG,20141217,N,MD,FR,FR,SUSTIVA,Fatigue;Rash pruritic;Urticaria,106600542,LT,,,106600542,1,20141027,20141106,,,106600542,1,HIV infection
10661479,106614791,1,I,,20141202,20141216,20141216,EXP,,2014HINLIT1051,HETERO,,45,YR,,M,N,,,20141215,N,OT,IN,,LAMIVUDINE+STAVUDINE+EFAVIRENZ (LAMIVUDINE+STAVUDINE+EFAVIRENZ),Angina pectoris;Cardiomyopathy;Gastritis;Immune system disorder;Mitral valve incompetence;Pulmonary tuberculosis;Treatment failure;Tuberculosis;Viral load increased,106614791,OT,106614791,FGN,106614791,1,200204,2005,91,DAY,106614791,1,HIV infection
10663053,106630532,2,F,,20141218,20141218,20141223,EXP,,DE-BMSGILMSD-2014-0127656,GILEAD,"HINCH M.C., REICHELT D, HUSSTEDT I.W. ACUTE PSYCHOSIS AS A SIDE EFFECT OF EFAVIRENZ THERAPY WITH METABOLIC ANOMALIES. AN IMPORTANT DIFFERENTIAL DIAGNOSIS OF HIV-ASSOCIATED PSYCHOSES. NUEROLOGIST. 2014;85 (10):1304-1308",52,YR,A,,Y,,,20141223,N,OT,DE,DE,EFAVIRENZ,Acute psychosis,106630532,OT,,,,,,,,,106630532,1,HIV infection
10663163,106631631,1,I,,20141215,20141218,20141218,EXP,,US-BMSGILMSD-2014-0127932,GILEAD,,50,YR,A,F,Y,,,20141218,N,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Blindness;Malaise,106631631,OT,,,,,,,,,106631631,1,HIV infection
10667064,106670641,1,I,20130125,20141208,20141218,20141218,EXP,,K201406768,VIIV,,23,YR,,F,N,,,20141217,N,MD,US,,SUSTIVA,Amniotic cavity infection;Delayed delivery;Gastrooesophageal reflux disease;Maternal exposure during pregnancy;Pregnancy,106670641,RI,106670641,HP,106670641,1,20120524,20130228,,,106670641,1,HIV infection
10667474,106674741,1,I,,20141015,20141218,20141218,EXP,,K201417016,VIIV,,33,YR,,M,N,,,20141217,N,,ZA,,EFAVIRENZ(EFAVIRENZ,Blindness;Hereditary optic atrophy;Vitamin B12 deficiency,106674741,RI,106674741,FGN,,,,,,,106674741,1,HIV infection
10667495,106674951,1,I,201410,20141217,20141222,20141222,EXP,,PHHY2014ZA165591,NOVARTIS,,59,YR,,F,Y,,,20141222,N,CN,COUNTRY NOT SPECIFIED,ZA,EFAVIRENZ,Acute hepatic failure;Cholestasis;Coagulopathy;Encephalopathy;Hepatosplenomegaly;Renal failure;Renal impairment;Sepsis;Tuberculosis,106674951,OT,,,106674951,1,201308,,,,106674951,1,Chronic myeloid leukaemia
10669196,106691961,1,I,20140918,20141216,20141222,20141222,EXP,,GB-ABBVIE-14P-167-1322591-00,ABBVIE,,60,YR,,F,Y,,,20141223,N,PH,GB,GB,EFAVIRENZ,Acute kidney injury,106691961,HO,,,,,,,,,106691961,1,Antiretroviral therapy
10670995,106709951,1,I,,20141015,20141219,20141219,EXP,,K201417019,VIIV,,31,YR,,M,N,,,20141217,N,,ZA,,EFAVIRENZ (EFAVIRENZ),Hereditary optic atrophy,106709951,RI,106709951,HP,,,,,,,106709951,1,HIV infection
10671033,106710331,1,I,20141106,20141211,20141219,20141219,EXP,,FR2014GSK018422,VIIV,,9,YR,,F,N,28.3,KG,20141217,N,MD,FR,,SUSTIVA,Drug hypersensitivity;Fatigue;Rash maculo-papular;Rash pruritic;Urticaria,106710331,LT,106710331,HP,106710331,1,20141027,20141106,,,106710331,1,HIV infection
10675075,106750751,1,I,20141204,20141209,20141224,20141224,EXP,,MW-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-002068,BRISTOL MYERS SQUIBB,,30,YR,,M,Y,59.8,KG,20141224,N,CN,MW,MW,EFAVIRENZ W/EMTRICITABINE/TENOFOVIR DISOPROXI,Acidosis;Ascites;Blood albumin decreased;Blood pressure diastolic increased;Generalised oedema;Heart rate increased;Hyponatraemia;Micturition frequency decreased;Normochromic normocytic anaemia;Pericardial effusion;Pleural effusion;Right ventricular failure,106750751,OT,,,106750751,1,20141204,20141205,,,106750751,1,Antiretroviral therapy
10675269,106752691,1,I,,20141219,20141224,20141224,EXP,,US-PFIZER INC-2014352856,PFIZER,"SINGH, S.N.. OUTCOMES AND CHEMOTHERAPY-RELATED TOXICITY IN HIV-INFECTED PATIENTS WITH BREAST CANCER.. CLINICAL BREAST CANCER. 2014;14 (2):E53-E59",,,,,Y,,,20141224,N,OT,US,US,EFAVIRENZ,Neurotoxicity,106752691,OT,,,,,,,,,106752691,1,Breast cancer
10677646,106776461,1,I,,20141217,20141229,20141229,EXP,,CA-ROCHE-1510165,ROCHE,REPORTER KNOWN TO AUTHORITY. UNKNOWN. ;:-.,52,YR,,M,Y,,,20141229,N,OT,CA,CA,SUSTIVA,Diplopia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Progressive external ophthalmoplegia,106776461,OT,,,,,,,,,106776461,1,HIV infection
10681609,106816091,1,I,20140516,20141118,20141224,20141224,EXP,,A1084018A,VIIV,,1,DY,N,M,N,1.7,KG,20141222,N,OT,MW,,EFAVIRENZ,Accessory auricle;Maternal drugs affecting foetus;Premature baby,106816091,CA,106816091,FGN,106816091,1,20110608,20140410,,,106816091,1,HIV infection
10683321,106833212,2,F,,20141215,20141230,20141230,EXP,,CA-GLAXOSMITHKLINE-B0598034A,GLAXOSMITHKLINE,,52,YR,,M,Y,,,20141230,N,MD,CA,CA,Efavirenz,Diplopia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Ophthalmoplegia,106833212,OT,,,,,,,,,106833212,1,HIV infection
10683900,106839001,1,I,,20141226,20141230,20141230,EXP,,US-GILEAD-2014-0129282,GILEAD,,25,YR,A,M,Y,,,20141230,N,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Death,106839001,OT,,,,,,,,,106839001,1,HIV infection
10685463,106854631,1,I,,20141217,20141231,20141231,EXP,,CA-PFIZER INC-2014360685,PFIZER,,52,YR,,M,Y,,,20141231,N,OT,CA,CA,SUSTIVA,Diplopia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Progressive external ophthalmoplegia,106854631,OT,,,,,,,,,106854631,1,HIV infection
7167449,71674492,2,F,,20141215,20091022,20141231,EXP,,B0598034A,VIIV,,52,YR,A,M,N,,,20141230,N,,COUNTRY NOT SPECIFIED,,EFAVIRENZ,Blood lactic acid increased;Diplopia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Ophthalmoplegia,71674492,OT,,,,,,,,,71674492,1,HIV infection
8602105,86021052,2,F,,20141205,20120607,20141219,EXP,,GB-RANBAXY-2012R1-56842,RANBAXY,"THNG C, BABIKER ZOE, BROWN B, BABU C. THE PERILS OF RELYING ON ANTI-HEPATITIS B TOTAL CORE ANTIBODY IN SCREENING INDIVIDUALS INFECTED WITH HIV. INT J STD AIDS. 2012;FEB;23(2):149-50",48,YR,,M,Y,,,20141219,N,MD,GB,GB,Efavirenz,Drug resistance;Gene mutation;Lipoatrophy;Transaminases increased;Vaccination failure,86021052,OT,,,86021052,1,200606,,,,86021052,1,Antiretroviral therapy
